Döhner, H., Müller-Tidow, C., Lübbert, M., Fiedler, W., Krämer, A., Westermann, J., . . . Ottmann, O. G. (2019). A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. British journal of haematology, 185(3), . https://doi.org/10.1111/bjh.15563
Chicago-Zitierstil (17. Ausg.)Döhner, Hartmut, et al. "A Phase I Trial Investigating the Aurora B Kinase Inhibitor BI 811283 in Combination with Cytarabine in Patients with Acute Myeloid Leukaemia." British Journal of Haematology 185, no. 3 (2019). https://doi.org/10.1111/bjh.15563.
MLA-Zitierstil (9. Ausg.)Döhner, Hartmut, et al. "A Phase I Trial Investigating the Aurora B Kinase Inhibitor BI 811283 in Combination with Cytarabine in Patients with Acute Myeloid Leukaemia." British Journal of Haematology, vol. 185, no. 3, 2019, https://doi.org/10.1111/bjh.15563.